Trxade Group

TRxADE HEALTH, Inc. provides an online platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focused on the United States pharmaceutical industry. The firm operates a web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. It also provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration and acts as a technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

Trxade Health Inc (NASDAQ:MEDS) shares are trading higher by 103.4% at $8.30 after the company announced the launch of its MedCheks health passport app for iOS devices. Trxade Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S.

Why MEDS Stock Is Skyrocketing Today

The stock price of Trxade Health Inc (NASDAQ: MEDS) increased by over 49% pre-market. This is why it happened.

MEDS Stock Price: Over 49% Increase Pre-Market Explanation

TAMPA, FL / ACCESSWIRE / June 1, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that its Board of Directors has authorized the repurchase of up to a maximum of $1.0 million of shares of the Company's common stock.

TRxADE HEALTH, INC. Announces Authorization of Stock Repurchase Program

CEO Suren Ajjarapu to Present Wednesday, June 9th, 2021 TAMPA, FL / ACCESSWIRE / May 28, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that management will present at the LD Micro Invitational XI investor conference taking place virtually June 8-10, 2021.

TRxADE HEALTH, INC to Present at LD Micro Invitational XI

TAMPA, FL / ACCESSWIRE / May 28, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that the Company will be changing its name to TRxADE HEALTH, Inc., effective Tuesday, June 1, 2021, to reflect its new mission and strategic direction of the business. The name change does not affect the rights of the Company's stockholders, creditors, customers or suppliers.

TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC.

TRxADE Telehealth Subsidiary Bonum Health to Provide Affordable Telemedicine Services to Patients at Leading Grocery Store Chain TAMPA, FL / ACCESSWIRE / May 6, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that its telehealth subsidiary, Bonum Health, has secured a strategic partnership with Brookshire Grocery Company ("BGC") and its diverse retail pharmacy network - spanning 180 corporate owned stores in Texas, Louisiana and Arkansas - to provide affordable telemedicine services. BGC plans to utilize a Bonum Health telemedicine program, combined with Bonum Health partner SingleCare's Prescription Savings Program, as a complete healthcare savings bundle aimed at uninsured and under-insured customers.

TRxADE Group Announces Strategic Telehealth Partnership with Brookshire Grocery Company

TRxADE Group Launches GPO+, a Next-Generation Group Purchasing Option for Drug Buying Groups TAMPA, FL / ACCESSWIRE / May 4, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy industry experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the signing of QualityCare Pharmacies, a New York-based independent pharmacy prescription drug buying group, as the newest member to join TRxADE's fast-growing Group Purchasing Organization (GPO+) to drive increased purchase volumes on the TRxADE platform. Active QualityCare pharmacy members will now qualify to receive highly competitive prescription drug pricing and first-of-kind GPO+ rebates, driving increased savings for members utilizing the TRxADE platform for drug purchases.

TRxADE Group Announces Milestone Group Purchasing Agreement with QualityCare Pharmacies

Health Passport Subsidiary Medcheks has Launched Next-Generation, Scalable Reopening Tools to Enable Expedited Post-COVID-19 Reopening to Align with Rapidly Evolving Global Mandates TAMPA, FL / ACCESSWIRE / April 28, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S., today announced the commercial launch of its government-targeted reopening solutions to address the rapidly evolving global mandates as the world reopens post-COVID-19. Medcheks' government health passport solutions include a suite of reopening tools, such as a personal health vaccination and verification app ("health passport") with an attractive pay-per-scan business model, risk assessment surveys, what we believe are best-in-class quarantine monitoring solutions and multi-purpose point-of-entry kiosk units that screen for COVID-19, perform temperature checks and read blood oxygen levels.

Trxade Group Announces Launch of Government-Oriented Heath Passport Solution to Enable Expedited Post-COVID-19 Reopening

Trxade Group, Inc. (MEDS) CEO Suren Ajjarapu on Q1 2021 Results - Earnings Call Transcript

Shares of Trxade Group (NASDAQ:MEDS) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 500.00% over the past year to ($0.08), which missed the estimate of ($0.05).

Recap: Trxade Group Q1 Earnings

First Quarter Revenues Increased 39% to $3.1 Million

TRxADE Group Reports Record First Quarter 2021 Financial Results

TAMPA, FL / ACCESSWIRE / April 12, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the first quarter 2021, after market close on April 26, 2021. Management will host a conference call on Monday, April 26, 2021 at 5:00 p.m.

Trxade Group to Report First Quarter 2021 Financial Results on Monday, April 26th at 5:00 p.m. Eastern Time

CEO Suren Ajjarapu to Present Wednesday, April 21st, 2021 TAMPA, FL / ACCESSWIRE / April 9, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that management will present at the Planet MicroCap Showcase taking place virtually April 20-22, 2021. Suren Ajjarapu, Chairman and Chief Executive Officer of TRxADE Group, is scheduled to host a virtual presentation and hold 1-on-1 meetings throughout the event as follows: Planet MicroCap Showcase Date: Wednesday, April 21, 2021 Time: 12:30 p.m.

TRxADE Group to Present at Planet MicroCap Showcase

Trxade Group, Inc.'s (MEDS) CEO Suren Ajjarapu on Q4 2020 Results - Earnings Call Transcript

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform

TRxADE Group Reports Annual Revenue Growth of 130% and Year End 2020 Financial Results

TAMPA, FL / ACCESSWIRE / March 15, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will release financial results for the fourth quarter and fiscal year ended December 31, 2020, after market close on March 29, 2021. Management will host a conference call on Monday, March 29, 2021 at 5:00 p.m.

Trxade Group to Report Fourth Quarter and Full Year 2020 Results on Monday, March 29th at 5:00 p.m. Eastern Time

TAMPA, FL / ACCESSWIRE / March 5, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, today announced that management will present at the following virtual investor conferences during the month of March 2021. Suren Ajjarapu, Chief Executive Officer of Trxade Group, is scheduled to host pre-recorded virtual presentations during each of the conferences as follows and will participate in one-on-one meetings throughout the day at each event.

Trxade Group to Present at March Investor Conferences

TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. ( MEDS ) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational investor conference taking place virtually on December 1, 2020.

TRxADE Group to Present at the Diamond Equity Research Emerging Growth Invitational

Amazon

Trxade Group Inc. (NASDAQ: MEDS) shares jumped on Tuesday after the company announced that it entered into a definitive agreement with Amazon.com Inc.

Trxade Group's Big New Deal With Amazon

Shares of Trxade Group Inc. soared 56% in active trading to pace all of the premarket's gainers Tuesday, after the online platform for pharmaceutical purchases announced a market program agreement with Amazon.com Services. Trading volume spiked up to 4.5 million shares, compared with the full-day average of about 160,000 shares.

News for Trxade Group Stock (MEDS)